Aging/Research reports/2026-10-12
TIMP2: Resolve sample structure before testing effects
Project status: 🔵 Level 2 · AG-C03 / AG-T01. Scientific evidence: preclinical literature, today a targeted metadata audit. No new efficacy finding.
What was resolved today
One further sample from the TIMP2 microglia paper is now specifically mapped. Important information remains inaccessible for two comparator samples. The decision is therefore: no inferential reanalysis yet on the basis of the sample manifest verified here. This does not establish that the dataset is unusable or contains a demonstrated error.
| Newly checked sample | Verified—and still unresolved |
|---|---|
| GSM9001954 | Second TIMP2 snRNA sample: wild type, male, 20 months, hippocampus; batch label 4.18.23, library TD006476-3. Two biological samples pooled after nuclear isolation. Individual animal/pool identifiers not verified. |
| GSM9001955 | Series index: second PBS snRNA sample. Complete batch, library and pooling fields not readable today; do not impute them from the TIMP2 sample. |
| GSM9001961 | Series index: third WT bulk sample. Complete sample fields not readable today; a matching replicate number does not establish pairing with a KO sample. |
Why this boundary matters
The three snRNA records fully read so far share a batch label. Our inference: The label describes a technical connection; it confirms neither distinct animals nor fully independent pools. The fourth sample remains unchecked in this respect. Missing information is not evidence of actual batch bias.
Yesterday’s audit already separated old treated wild-type hippocampi from neonatal WT/KO microglia. These series do not form a joint genotype-by-treatment experiment. Any later analysis must distinguish observed libraries, biological pools and treated animals. Many nuclei do not automatically increase the number of independent treatments. Alternative explanations remain cell composition, developmental stage, culture and processing. Previous finding and dataset sources.
Evidence and the next decision
Established knowledge within the audit: the explicitly read metadata. Promising indications: earlier TIMP2 functional findings, without additional support today. Experimental results: external animal/cell studies; no new project measurements. Hypothesis: selective cargo degradation with preserved synapses and improved function. AG-T01 remains at Level 2 with low mechanistic confidence. Benefit after withdrawal, human efficacy and adequate safety are not established.
The project parks further similar GEO requests until new regular access or explicit file/pool mapping becomes available. Unknown fields remain unknown; no substitute values or effect calculations. The next separate evidence route is a newly located institutional original PDF of AG-D06. Check score definition, APOE/cis sensitivity, covariates and uncertainty. This PDF was not opened today; an accessible supplement is not thereby established.
Source status and teaching
- AG-R01: Hemmer, Philippi et al., Nature Communications, 12 August 2026, DOI 10.1038/s41467-026-74906-z. The original paper is not counted again as a new source.
- Retrieved: 12 October 2026. Indexed official GEO metadata; two newly targeted sample requests returned no retrievable content. No matrix/raw-data analysis or complete new methods appraisal. Notice check of 10 October not repeated. Source delta 0: 28 studies.
- The INTACT-olotl axolotl lead remains outside evidence appraisal because its original text has not been verified. Search log.
- AG-P21 of 11 October already covers this methods question. The bilingual draft remains saved; its package and wishlist entry are still unpublished. No duplicate. Research colloquium · Evidence chain · Approaches registry.
Continue exploring
